Evidence map›Paper›PMID 21884934›Full record

ArticleCell2011

Control of embryonic stem cell lineage commitment by core promoter factor, TAF3.

Zhe Liu, Devin R Scannell, Michael B Eisen, Robert Tjian

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reader-Effectors as Actuators of Epigenome Editing.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. A cohesin traffic pattern genetically linked to gene regulation.Nature structural & molecular biology · 2022
    Article
  14. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zhe LiuHoward Hughes Medical Institute, Molecular and Cell Biology Department, University of California, Berkeley, Berkeley, CA 94720, USA.
Devin R Scannell
Michael B Eisen
Robert Tjian
University of California, Berkeley · USHoward Hughes Medical Institute · US

Funding

THE SV40 TUMOR ANTIGENR37CA025417 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI TJIAN, ROBERT TSE NAN · 1987 to 2013
$6.8M
Howard Hughes Medical InstituteNCI NIH HHS R37 CA025417
6 · The paper itself

Abstract

Deciphering the molecular basis of pluripotency is fundamental to our understanding of development and embryonic stem cell function. Here, we report that TAF3, a TBP-associated core promoter factor, is highly enriched in ES cells. In this context, TAF3 is required for endoderm lineage differentiation and prevents premature specification of neuroectoderm and mesoderm. In addition to its role in the core promoter recognition complex TFIID, genome-wide binding studies reveal that TAF3 localizes to a subset of chromosomal regions bound by CTCF/cohesin that are selectively associated with genes upregulated by TAF3. Notably, CTCF directly recruits TAF3 to promoter distal sites and TAF3-dependent DNA looping is observed between the promoter distal sites and core promoters occupied by TAF3/CTCF/cohesin. Together, our findings support a new role of TAF3 in mediating long-range chromatin regulatory interactions that safeguard the finely-balanced transcriptional programs underlying pluripotency.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCCCTC-Binding FactorCell Cycle ProteinsCell ProliferationChromosomal Proteins, Non-HistoneCohesinsEmbryonic Stem CellsEndodermHomeodomain ProteinsHumansMicePromoter Regions, GeneticRepressor ProteinsTATA-Binding Protein Associated FactorsTeratomaCCCTC-Binding FactorCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsCTCF protein, humanCtcf protein, mouseHomeodomain ProteinsRepressor ProteinsTAF3 protein, humanTaf3 protein, mouseTATA-Binding Protein Associated FactorsTranscription Factor TFIID

Identifiers

PMID21884934
PMCPMC3191068
OpenAlexW1984015499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.